The University of Alabama at Birmingham

Birmingham, Alabama 35294-0111

31 studies enrolling now · 138 studies all time

What they study most

ALK-positive Histiocytosis, Acne Inversa, Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Acute Renal Failure, Adjuvant Arthritis, Advanced Breast Cancer, Advanced or Metastatic Solid Tumors, Adverse Pregnancy Outcomes, Aging, Alopecia Areata, Aneurysmal Subarachnoid Hemorrhage (aSAH), Anxiety

Studies at this site

• Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors — Recruiting now
• Pridopidine Phase 3 Study in Huntington's Disease — Recruiting now
• Biomarkers to Enhance Early Schizophrenia Treatment — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors — Recruiting now
• Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology — Recruiting now
• DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma — Recruiting now
• Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer — Recruiting now
• A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue — Recruiting now
• A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) — Recruiting now
• A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients — Recruiting now
• Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital — Recruiting now
• Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants — Recruiting now
• Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI — Recruiting now
• Ensuring Access to Optimal Therapy in CF: The ENACT Study — Recruiting now
• Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis — Recruiting now
• Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy — Recruiting now
• A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms — Recruiting now
• Prevail Global Study — Recruiting now
• VENTURI (VENTilation Using Respiratory Imaging) — Recruiting now
• Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children — Recruiting now
• A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF — Recruiting now
• Blue Light Cystoscopy With Cysview® Registry — Recruiting now
• Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators — Recruiting now
• International Rare Histiocytic Disorders Registry (IRHDR) — Recruiting now
• Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ — Recruiting now
• A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) — Completed
• A Community Health Worker Intervention to Address Adverse Pregnancy Outcomes — Completed
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Semaglutide for Low Back Pain — Starting soon
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — Enrolling by invitation
• Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS) — Starting soon
• Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas — Starting soon
• A Study of SGN-MesoC2 in Advanced Solid Tumors — Stopped early
• A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed Therapies — Running, not enrolling
• Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging — Withdrawn before enrolling
• Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI — Completed
• Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H) — Completed
• The Nuestros Días ("Our Days") Study — Running, not enrolling
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) — Stopped early
• Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial — Completed
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• The Impact of Brief Behavioral Treatment for Insomnia Versus Brief Mindfulness Treatment on Cognition and Sleep Health in Adults (Age 50+) With HIV — Starting soon
• Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis — Completed
• Long-Term PF-06651600 for the Treatment of Alopecia Areata — Completed
• Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS — Completed
• Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma — Running, not enrolling
• A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. — Stopped early
• Bodewell Products for the Treatment of Atopic Dermatitis — Running, not enrolling
• REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors — Completed